These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 17011235)

  • 1. Strategies for developing vaccines against H5N1 influenza A viruses.
    Horimoto T; Kawaoka Y
    Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
    Hasegawa H; Ichinohe T; Tamura S; Kurata T
    Expert Rev Vaccines; 2007 Apr; 6(2):193-201. PubMed ID: 17408369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?
    Pappaioanou M
    Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):287-300. PubMed ID: 19318178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influenza type A (H5N1) virus infection].
    Engin A
    Mikrobiyol Bul; 2007 Jul; 41(3):485-94. PubMed ID: 17933264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spread of avian influenza H5N1 virus; a pandemic threat to mankind.
    Chutinimitkul S; Payungporn S; Chieochansin T; Suwannakarn K; Theamboonlers A; Poovorawan Y
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S218-33. PubMed ID: 17722309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.
    Swayne DE; Beck JR; Perdue ML; Beard CW
    Avian Dis; 2001; 45(2):355-65. PubMed ID: 11417815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus A (H5N1): a pandemic risk?
    Babakir-Mina M; Balestra E; Perno CF; Aquaro S
    New Microbiol; 2007 Apr; 30(2):65-78. PubMed ID: 17619249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccines and vaccination strategies in birds.
    van den Berg T; Lambrecht B; Marché S; Steensels M; Van Borm S; Bublot M
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):121-65. PubMed ID: 17889937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza: lessons from past pandemics, warnings from current incidents.
    Horimoto T; Kawaoka Y
    Nat Rev Microbiol; 2005 Aug; 3(8):591-600. PubMed ID: 16064053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genesis of pandemic influenza.
    Sorrell EM; Ramirez-Nieto GC; Gomez-Osorio IG; Perez DR
    Cytogenet Genome Res; 2007; 117(1-4):394-402. PubMed ID: 17675883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
    Swayne DE
    Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Adv Virus Res; 2009; 73():55-97. PubMed ID: 19695381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines developed for H5 highly pathogenic avian influenza in China.
    Qiao C; Tian G; Jiang Y; Li Y; Shi J; Yu K; Chen H
    Ann N Y Acad Sci; 2006 Oct; 1081():182-92. PubMed ID: 17135510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update].
    Loulergue P; Launay O
    Med Sci (Paris); 2009; 25(8-9):719-25. PubMed ID: 19765386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A (H5N1) pandemic prototype vaccine Fluval.
    Vajo Z
    Expert Rev Vaccines; 2009 May; 8(5):619-24. PubMed ID: 19397418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.